borderline significantp = 0.05
At week 4, the celecoxib + prednisolone group showed borderline significantly greater ROM (104.10 ± 14.05 vs. 97.44 ± 16.43; p = 0.05).
At week 4, the celecoxib + prednisolone group showed borderline significantly greater ROM (104.10 ± 14.05 vs. 97.44 ± 16.43; p = 0.05).
Improvement was clinically confirmed by controlling for the effect of age with borderline significance.